As per our report, the global contraceptives market size is estimated to grow USD 53.03 billion by 2026 from USD 38.4 billion in 2021, registering a CAGR of 6.67 % during the forecast period.
Contraception is preventing pregnancy by interfering with the normal process of fertilization, ovulation, and implantation through drugs, barriers, medical devices, and surgical techniques. They are the drugs that will also inhibit sexually transmitted diseases. These devices are available in different forms, such as loop, coil, T-shaped, and triangle, mostly made up of plastic or metal. The trend witnessed in this market is the development of products such as vaginal rings, self-administrative contraceptive injections, sub-dermal contraceptive implants, non-surgical permanent contraception devices, etc.
MARKET DRIVERS:
The major drivers that influence the market are increasing the development of useful female contraceptive devices and drugs, technological advancements, increasing initiatives from government and NGO to promote contraceptives, implementing the patient protection act, and rising global prevalence of sexually transmitted infections (STI). Instead of critical family procedures, new permanent contraceptives are the primary driver in low-income countries.
The major factors driving the growth of contraceptive drugs and devices include the growing incidence of STDs, rising rates of unintended pregnancies, and increasing government initiatives. Also, countries and their respective governments have identified the need to curb the growth of unwanted pregnancies and have launched a large number of initiatives to educate and prevent the spread of unintended pregnancies and abortions. One of these is the use of contraceptive pills.
The right to acquire and use contraceptives is part of the fundamental right to privacy enshrined in the Constitution of the United States. Government initiatives also promote the use of contraceptives to avoid unnecessary births. Too significant for the key players in the growth of this market were the health benefits of using contraceptives. Additionally, there are many technological advances in contraceptive drugs, such as developing emergency oral contraceptive pills, that have contributed to market growth.
MARKET RESTRAINTS:
Restraints that are hampering the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility. The contraceptives market is predicted to grow rapidly due to increasing awareness in making the right decisions about their sexual and reproductive health.
Impact of COVID-19 on the global contraceptives market:
The COVID-19 pandemic has prominently impacted the contraceptives market negatively. The pandemic has changed the social and economic realities of people's lives. Due to the limitations during the lockdown in visiting their physicians without any emergency, the contraceptives market has got deficient demand during the initial period of a pandemic. The healthcare domain has itself announced to use telehealth services and virtual consultation with the patients for screening and counseling. According to the United Nations sexual and reproductive health agency (UNFPA), around 47 million women lost access to contraception, where 7 million have unintended pregnancies only due to COVID 19 crisis. The market shares to be in a normal position by 2021.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Drug Type, Medical Devices, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This market research report on the global contraceptives market has been segmented and sub-segmented based on the drug type, medical devices, end-user, and region.
Contraceptives Market - By Drug Type:
Throughout the forecast period, Contraceptive Pills are anticipated to record the highest share in the market. Contraceptive pills are considered to be the industry's easiest contraceptive method. If taken within 2-3 days of unsafe sexual contact, they prohibit implantation within the uterus. A growing number of unwanted pregnancies, ongoing advancements in technologies relevant to contraceptives, and the rising occurrence of sexually transmitted diseases are surging the contraceptives market growth. The huge consumer populace and government initiatives to fulfill the unmet needs of the women of the reproduction age boost the growth rate of the market during the forecasting framework.
The others (Contraceptive gels, jellies, and creams) segment is anticipated to have a substantial growth rate in the market over the analysis period.
Contraceptives Market - By Medical Devices:
Based on medical devices, Condoms are the world's most popular choice and have the largest market share. Copper IUD is predominantly preferred by women who do not want to use hormonal shape to avoid potential side effects. The segment is rapidly adopted worldwide, and during the forecast period, will continue to grow. These IUDs have got very high success rate.
Moreover, the other segments such as subdermal, male, and female condoms and the rest are likely to have considerable market growth in terms of revenue. Intensifying demand for contraceptives might rise due to the growth in the number of HIV infections across many countries over the upcoming years.
Contraceptives Market - By End User:
Based on the end-user, the hospital's segment is accounted for the largest shares in the market. These contraceptive devices are majorly used in hospitals, particularly in the gynecology sector. The Homecare segment is foreseen to have notable growth in the contraceptives market. Increasing initiatives by the government in creating awareness in people relevant to unwanted pregnancies and growing population are propelling the demand of the market. The clinic's segment is also expected to grow at a higher rate during the forecast period.
Contraceptives Market - By Region:
Due to the presence of advanced healthcare facilities, the high adoption rate of contraceptive drugs, and the growing number of government initiatives that help to increase the overall market, North America is expected to register high growth. A large female population section represents the reproductive age in both the United States and Canada.
As the partners do not use a contraceptive method correctly and consistently, a significant size of the population is at risk of unintended pregnancy. Besides, several companies ' distribution channel is well established across the U.S. and Canada, driving the market overall and contributing to the largest share over the forecast period.
NOTABLE COMPANIES IN THIS MARKET:
Companies leading the global contraceptives market profiled in the report are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc., Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., Cooper Surgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc. and Pfizer, Inc.
MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
Holoxica Limited (UK) unveiled the world's first 3D digital hologram of human brain fiber pathways in May 2016. This new brain path imaging enables neurosurgeons and clinicians to identify, diagnose, and treat various neurological conditions, including Alzheimer's, MND, stroke, and cancer.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Drug type
5.1.1 Contraceptive pills
5.1.2 Topical contraceptives
5.1.3 Contraceptive injectable
5.1.4 Others (contraceptive gels, jellies and creams)
5.2 By Medical Devices
5.2.1 Male contraceptive devices
5.2.2 Female contraceptive devices
5.2.2.1 Female condoms
5.2.2.2 Intrauterine devices
5.2.2.3 Contraceptive sponges
5.2.2.4 Contraceptive diaphragms
5.2.2.5 Contraceptive patches
5.2.2.6 Subdermal contraceptive implants
5.2.2.7 Non-surgical permanent contraceptive devices
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer HealthCare AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Teva Pharmaceutical Industries Limited
8.3 Medisafe Distribution Inc
8.4 Pace Pharmaceuticals Inc
8.5 Medicines360
8.6 Church & Dwight, Co., Inc.
8.7 Actavis, Inc
8.8 CooperSurgical
8.9 Merck & Co., Inc
8.10 Reckitt Benckiser plc
8.11 Mayer Laboratories, Inc
8.12 Pfizer, Inc
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market outlook and Investment oppurtunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
